chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A LOT LESS MOBILITY; CAN'T LIFT ARM UP; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported.  On an unspecified date, the patient experienced a lot less mobility, and can't lift arm up. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the a lot less mobility and can't lift arm up was not reported. This report was non-serious.
This spontaneous report as received from a physician refers to a 4 year old patient (also reported as a child) of unknown gender. The patient's concurrent conditions. medical history and concomitant medications were not provided. On 06-APR-2016 (also reported as today), the patient was inadvertently vaccinated subcutaneously with a 0.5 ml dose of VARIVAX (Merck) injection (lot # L017997, expiration date 19-MAY-2017, in the left arm) and PROQUAD (Merck) (lot # reported as L051102, expiration date 17-JUN-2017, dose, route of administration and anatomical location were not specified). No adverse effects were reported. Additional information has been requested.
About the day after the first vaccine, I started having sharp pain in my joints and in my left leg, they were sharp shooting pains.  Now, I have them periodically in the joints of my fingers.  Also, my right hand periodically gets swollen and I have joint pain in my pointer and pinky fingers.
Patient states she had swelling in arm for a few weeks and now has a lump under the skin on injection arm
Pt has a history of fainting after I.M. injections. Pt states she is feeling faint and may pass out. Pt was moved to the exam room and monitored. Pts vitals are stable. Pt states she is feeling better. Pt requested to leave. Pt didnt require transport to hospital.
3 days p/immun pt devel rash & resp distress; Cefzil stopped & other sx resolved;
Fever and muscle aches began approximately 18 hours after injection, and continued for approximately 18 hours after onset of symptoms.
Rec'd Moderna Dose #2 and developed HA, chills and tingling sensation in her fingers. Rash reportedly appeared on her arm. Rec'd Benadryl and rash disappeared. After a nap that day, pt awoke with SOB, palpitations, dizziness, and rash returned on right arm and right neck. Came to ED for evaluation (6/22/21 @ 0514). Tachycardic. In ED, pt's mother noted pt would say something & then repeat what she said seconds later. Dx with seizure in ED and given Ativan 2mg IV. CXR, CT of head, and CTA of chest were all unremarkable. Afebrile, WBC normal, no COVID-19 detected. Pt admitted to ICU for further evaluation and treatment.  Also had seizure-like activity during ID MD's exam 6/23/21.
Initial unsolicited report received from a consumer (patient) on 14 Jul 2016. This case involves an 84-year-old male patient who was administered with first dose of ADACEL (batch number: C4990AA, expiration date 27 May 2018) (dose detail was not reported) by intramuscularly in left deltoid on 07 July 2016. Patient's medical history and concomitant medications were not reported. The patient was allergic to penicillin, quinine and formaldehyde. On 08 July 2016, one day following vaccination, the patient developed itchy rash on left arm, it was reported that the patient was diagnosed with shingles of left arm after four days of vaccination. The patient required ER/doctor visit. Laboratory investigations were not reported. The patient was prescribed with antiviral valacyclovir (3 pills daily), calamine lotion and compresses. The outcome of the events was reported as unknown. List of documents held by sender: none.
painful shoulder; couldn't sleep; nor reach out 4 anything; This case was reported by a consumer via interactive digital media and described the occurrence of shoulder pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 10th September 2021, the patient received Shingles vaccine. In September 2021, less than a week after receiving Shingles vaccine, the patient experienced shoulder pain, sleeplessness and mobility decreased. On an unknown date, the outcome of the shoulder pain, sleeplessness and mobility decreased were unknown.   It was unknown if the reporter considered the shoulder pain, sleeplessness and mobility decreased to be related to Shingles vaccine.  Additional details provided were as follows: The case was reported by patient himself/herself. The patient received a dose of Shingles vaccine a day ago of the reporting day and could not sleep nor reach out for any thing due to painful shoulder. The patient was hoping that the shot was worth the pain. Follow-up would not be possible as no contact details available.
tested positive for COVID; sore at the injection spot; Had a small fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID), INJECTION SITE PAIN (sore at the injection spot) and PYREXIA (Had a small fever) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (tested positive for COVID), INJECTION SITE PAIN (sore at the injection spot) and PYREXIA (Had a small fever). At the time of the report, COVID-19 (tested positive for COVID), INJECTION SITE PAIN (sore at the injection spot) and PYREXIA (Had a small fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive.     For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   The concomitant medication was not reported by reporter. The treatment medication was not reported by reporter.  Patient received the latest Moderna Spikevax. The next day patient felt horrible. Had a small fever, headache and achy. After that, felt fine, just sore at the injection spot. 8 days later patient felt run down and tested positive for COVID, had congestion, headache and fever. Continued to test positive for the next 7 days. The side effects of Covid were less than the vaccine itself.   Most recent FOLLOW-UP information incorporated above includes: On 07-Oct-2023: Live follow-up received. Reference numbers were added.
COVID 19 Treatment/ tested positive for COVID; COVID 19 Treatment/ tested positive for COVID; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 54-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "pulmonary stenosis" (unspecified if ongoing); "ocular myasthenia gravis" (unspecified if ongoing); "1 kidney (congenital)" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Cephalosporins, reaction(s): "Drug allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 31Aug2023, outcome "unknown" and all described as "COVID 19 Treatment/ tested positive for COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (31Aug2023) positive, notes: tested positive for COVID. Therapeutic measures were taken as a result of drug ineffective, covid-19 including Paxlovid from 31Aug2023 to 05Sep2023.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information, a lack of efficacy with the suspect vaccine BNT162B2 in this patient cannot be completely excluded.
Patient arrived for Hepatitis A #2. Patient was well. Given immunization. Five minutes later fainted while standing up. Given juice, crackers, BP taken.
The client completed pre exposure vaccine series in the past.  Was bitten by a bat on Thursday, August 2nd.  Went to a different facility and states she received Imovax 2.5cc which I questioned because that was not the appropriate dose.  Client swears she saw the 3cc syringe herself with the "pink vaccine" in it.  She said she had a headache later that day and felt generally unwell after the shot.  She said it is documented that she Imovax 2.5ml on her discharge papers from the other facility and that she told them that they were not to give her immune globulin so they didn't.  She had her second post exposure rabies vaccine from us on Sunday, August 5th per protocol and later that afternoon felt nauseous, dizzy, fell in her kitchen, vomited several times and had HA.  She took a nausea pill which she thinks was Zofran.  All symptoms spontaneously resolved by Monday, August 6th.  She insisted that I file this report as a vaccine reaction.  There is no injection site reaction.
This spontaneous report was received from a pharmacist refers to a 75 year old patient of unknown gender. On 28-SEP-2012, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot number was reported as 0595AA expiration date 30-AUG-2012). Concomitant medications were not reported. The reporter stated that the patient received PNEUMOVAX 23 on 28-SEP-2012 that had expired on 30-AUG-2012. The patient did not have a prior history of vaccination with PNEUMOVAX 23. No adverse event was reported. This is a report received from the same reporter. Additional information has been requested.
This spontaneous report was received from a pharmacist and refers to a 76-year-old male patient. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On an unknown date in June 2016, the patient was vaccinated with PREVENAR 13. On an unknown date in August 2016 (reported as 2 months later), the patient was vaccinated with PNEUMOVAX 23 (exact dose, frequency, site and route of administration, lot# and expiration date were not reported) for prophylaxis. The patient was immunocompetent. No adverse effects were reported.
This spontaneous report as received from a 57 year old female patient and her husband via a company representative refers to the patient herself. There was no information about medical history/concurrent conditions and concomitant medication. On approximately 23-APR-2014 (reported as "about 2 and 1/2 weeks ago") the patient was vaccinated with a dose of ZOSTAVAX, subcutaneous in the abdomen (lot# and dose unspecified). The patient stated that "it was administered as a 'deep subcutaneous injection'". In approximately April 2014 (reported as "within 24 hours after receiving ZOSTAVAX"), the patient developed an inch-size red circle around the injection site that was sore and there was no rash. The patient did not seek medical attention. The patient recovered in approximately April 2014 (reported as "3 to 5 days after the onset of her symptoms"). Additional information has been requested.
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced HEADACHE (Headache). On 09-Apr-2021, HEADACHE (Headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-072912 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-072912:Second dose case
BODY ACHES; This spontaneous report received from a patient concerned a 62 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, expiry: UNKNOWN) dose was not reported, administered on 03-JUN-2021 for prophylactic vaccination. No concomitant medications were reported.  On 04-JUN-2021, the subject experienced body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body aches. This report was non-serious.
Pt reported chest tightness and warmth of his ears and eyes.  Vital signs were stable Pt was given Benadryl 25mg PO and observed in Medical tent until symptom resolution
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 69-year-old male patient received BNT162b2 (BNT162B2), on 24Oct2021 as dose 3 (booster), single (Lot number: Ff2590) at the age of 68 years, in left arm for Covid-19 immunisation; coviD-19 vaccine miRNA (miRNA 1273) (MODERNA COVID-19 VACCINE), on 31Jan2021 as dose 1, single (Lot number: 007M20A), in left arm, on 28Feb2021 as dose 2, single (Lot number: 025A21A), in left arm and on 28Feb2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for Covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results. Therapeutic measures were taken as a result of drug ineffective, Covid-19. Additional Information: Covid infection and severe symptoms returned three days after completing Paxlovid. Patient was not recovered. No treatment received for AE. No other medical history was reported. Vaccine received was yes. No other medication in 2 weeks. No follow up attempts are needed. No further information is expected
Information has been received from a medical assistant concerning a 34 day old patient who on 01-OCT-2010 was vaccinated intramuscularly with a 0.5 ml dose of VAQTA (Lot # no reported) instead of hepatitis B virus vaccine. No adverse reactions were reported. Follow up information had been received from the medical assistant concerning a 34 day old male patient who on 01-OCT-2010 was vaccinated with a first dose of VAQTA (Lot # 667859/0569Z) in the left. No adverse reactions were reported. Additional information is not expected.
Dizziness, Headache, Myalgia, Fever, SkinRash, Tachypnea, Rash, NauseaVomiting, Tachycardia, driving; had to pull over due to "black out."  Narrative: Employee notified her provider the following Monday, 3/28/21. Provider instructed her to rest.
Abnormal heavy/ clotting period.; Abnormal heavy/ clotting period.; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 39 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: HEAVY MENSTRUAL BLEEDING (non-serious), MENSTRUAL DISORDER (non-serious) all with onset 12Oct2021, outcome "unknown" and all described as "Abnormal heavy/ clotting period.". Therapeutic measures were not taken as a result of heavy menstrual bleeding, menstrual disorder.  Additional information: Facility type Vaccine: Pharmacy or Drug Store. Known allergies: No. Other vaccine in four weeks: No. Other medications in two weeks: No. Covid prior vaccination: No. Covid tested post vaccination: No.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Patient experienced welling and redness over the first 3 days after administration of 2nd Shingrix vaccine. Patient experienced a rash lasting around 7 days. Patient was informed of the potential adverse effects and to report them to our pharmacy if they occur. Patient does not have any residual effects.
Had it twice I got the Shingles vaccine also/suspected vaccination failure; had it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported as follows: The patient had the shingles twice and you did not want it, was just hell. The patient got the Shingles vaccine also and then it was not supposed to get shingles more than once but the patient did and it was nasty. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Woke up at 4am I had to vomit and I had to sit on the toilet at the same time. I was in so much pain all over my body shaking and I had a fever. I felt like I had glass in my joints because the pain was so bad. I was pouring wet from sweat. I had to change the bed because it was wet from the sweat. I also had a really bad headache. I was in so much pain it hurt all over. Then I went back to bed and I couldn't eat and keep anything down. My fever didn't break for 4 days at least I was in the bed for about 10 days I really don't want anymore shots because this was so bad. I also got COVID in January and was really sick. I still feel sick I joint issues my bones hurt. I feel like I have glass in my knee and sometimes I just sit and cry because nobody can give me answers. I also have major headaches. I also have skin irritations where just itches it turn lobster red from time to time.
After 2nd 1st day migrain again; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Sep2021 15:00 (Batch/Lot number: unknown) at the age of 42 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1, Anatomical location: Arm left, Administration time: 15:00), administration date: 01Sep2021, when the patient was 42 years old, for COVID-19 immunization, reaction(s): "Shoulder pain", "left knee feel sore", "Migrain turned to headache", "Migrain turned to headache", "Heart piercing 1st two weeks". The following information was reported: MIGRAINE (non-serious) with onset Sep2021, outcome "unknown", described as "After 2nd 1st day migrain again".  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient had no Known allergies.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Uncontrollable crying for 4-5 hours with DTaP. Fever of 102 with DTaP (6/10/11). Fever of 104 degrees F with PREVNAR (7/5/11).
symptoms started at 1530- achy, sharp shooting left sided chest pain, HA, nausea, and dizziness. Progressed throughout evening, CP became more progressive, increase in HR, shaky uncontrollable all over, temp. 101.5 (9:15pm). Started vomiting and diarrhea by 9:26pm. CP, HA progressed throughout evening and into the next day. I was unable to get out of bed at on 10/3/21, couldn't eat or drink. Called PCP 10/4/21 due to still having symptoms of CP, HA, severe dizziness and fatigue. Was seen by 9am on 10/4/21. PCP did labs and EKG which showed changes from baseline in 7/2021. Started on 325mg of ASA, decadron, zofran, and tramadol for HA.  Dizziness, CP, and HA have persisted along with intermittent left calf pain. Currently under care of PCP, which was seen 10/7/21 for follow up and further lab testing as there have been changes to EKG, and clotting studies.  Will continue to be monitored and further tests to come such as ECHO and blood work. Was started on Plavix 10/7/21 in addition to ASA.
3/9/09, tingling in jaw and lips, very mild. 3/12/09, spasms in jaw and face itching. BENADRYL 25mg. For one per day q6h prn itching. 3/18/09, office visit, same symptoms. Information about vaccine, reassurance given.
Mom reported to me on 4-28-10 that her son had vomiting 4 days after receiving ROTATEQ and PENTACEL vaccines (vaccines given on 4-21-10). Has had slightly loose stool, yellow and frothy in last few days, some congestion but otherwise well. Was not seen.
(Lt) thigh redness and raised whelp at the injection site. (Rt) thigh redness at the injection site. MOTRIN and BENADRYL given and cool compress to both injection sites.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a elderly female patient who received Shingles vaccine for prophylaxis. The patient's past medical history included shingles (in 1972). In October 2018, the patient received the 1st dose of Shingles vaccine. In October 2018, less than a month after receiving Shingles vaccine, the patient experienced injection site pain and vaccine administered at inappropriate site. On an unknown date, the outcome of the injection site pain and vaccine administered at inappropriate site were unknown. It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine. Additional details were reported as follows: The patient received a shingles vaccine a week before the date of reporting at her physician's office. The patient was unsure about it being a first dose of two because she was not told to return for 2nd dose. The patient noted it was the first shingles vaccine she had received. The patient received the shot in her left hip area of her upper buttocks area, which led to inappropriate site of vaccination. The patient noted it hurt, like she had hit something but there was no bruise. No other events were noted.